Rita K. Schmutzler
University of Cologne(DE)Centrum für Integrierte Onkologie(DE)University Hospital Cologne(DE)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Ovarian cancer diagnosis and treatment, Genetic factors in colorectal cancer, Genetic Associations and Epidemiology
Most-Cited Works
- → Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation(2014)1,667 cited
- → Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer(2022)414 cited
- → Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy(2015)298 cited
- → Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto(2018)296 cited
- → Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study(2014)248 cited
- → Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers